NLM Logo

MRC AML 10 protocol MeSH Supplementary Concept Data 2024


MeSH Supplementary
MRC AML 10 protocol
Unique ID
C518484
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C518484
Registry Number
0
Heading Mapped to
Amsacrine
*Antineoplastic Combined Chemotherapy Protocols
Cytarabine
Daunorubicin
Etoposide
Mitoxantrone
Frequency
1
Note
chemotherapy protocol consisting of above cpds for treatment of acute myeloid leukemia
Source
Pediatr Blood Cancer 2007 Mar;48(3):262-7
Date of Entry
2007/03/31
MRC AML 10 protocol Preferred
page delivered in 0.005s